INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 70 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $440,910 | -38.3% | 13,944 | -20.4% | 0.00% | – |
Q2 2023 | $714,099 | +94.1% | 17,511 | +77.4% | 0.00% | – |
Q1 2023 | $367,818 | -2.3% | 9,869 | -8.5% | 0.00% | – |
Q4 2022 | $376,464 | -36.0% | 10,790 | +2.8% | 0.00% | – |
Q3 2022 | $588,000 | -97.6% | 10,492 | -97.8% | 0.00% | -100.0% |
Q2 2022 | $24,156,000 | -65.6% | 466,673 | -51.7% | 0.01% | -57.1% |
Q1 2022 | $70,245,000 | -47.4% | 966,638 | -14.4% | 0.03% | -41.7% |
Q4 2021 | $133,562,000 | +1.7% | 1,129,581 | +15.3% | 0.05% | -2.0% |
Q3 2021 | $131,393,000 | +108.0% | 979,450 | +151.0% | 0.05% | +104.2% |
Q2 2021 | $63,169,000 | +5787.1% | 390,148 | +2815.7% | 0.02% | – |
Q1 2021 | $1,073,000 | +135.8% | 13,381 | +59.7% | 0.00% | – |
Q4 2020 | $455,000 | -89.2% | 8,377 | -97.2% | 0.00% | -100.0% |
Q1 2017 | $4,227,000 | +7.5% | 300,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $3,933,000 | -23.0% | 300,000 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $5,106,000 | -20.3% | 300,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $6,405,000 | – | 300,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |